Our present findings support the theory that PTX3 may be a potentially modifiable risk factor for atherosclerosis and that adiponectin may provide potentially substantial clinical benefits in the stabilization of carotid plaques. The gene discussed is ADIPOQ; the disease is atherosclerosis.